期刊文献+

甲亢和甲减患者血清PTH、CT水平的变化 被引量:4

Changes of Serum PTH and CT levels in Hyperthyroidism and Hhypothyroidism
暂未订购
导出
摘要 目的 :探讨了甲亢和甲减患者血清甲状旁腺素 (PTH)和降钙素 (CT)水平的变化。方法 :应用放射免疫分析法测定了 6 2例甲亢患者和 32例原发性甲减患者血清中PTH、CT含量 ,并以 35名健康人作对照。结果 :甲亢组血清PTH水平低于正常人组 (P <0 .0 5 )、甲减组高于正常人组 (P <0 .0 1) ,CT水平两组均低于正常人组 (P <0 .0 1)。结论 :测定甲亢和甲减病人血清中PTH、CT水平的变化对了解病情 ,指导临床实践均有重要的临床意义。 Objective To explore the serum level changes of parathyroid hormone(PTH) and Calcitonin(CT) in hyperthyroid-and hypothyroid-patients. Methods Serum parathyroid hormone and Calcitonin levels were determined With RIA in 62 cases of hyperthyroidism, 32 cases of hypotlyroidism and 35 normal Controls. Results The serum PTH levels in patients with hyperthyroidism were lower than those in controls ( P <0.05); the PTH levels in patients with hypothroidism were high than normal ( P <0.01). The serum CT levels were decreased both in hyperthyroid and hypothyroid patients ( P <0.01). Conclusion Determination of changes of serum PTH and CT levels in hyperthyroidism and hypothyroidism was of important clinical Significance.
出处 《放射免疫学杂志》 CAS 2001年第3期134-135,共2页 Journal of Radioimmanology
关键词 甲状腺功能亢进 甲状腺功能减退 甲状旁腺素 降钙素 hyperthyroidism, hypothyroidism, parathyroid hormone (PTH), calcitonin (CT)
  • 相关文献

参考文献2

二级参考文献1

  • 1郑法雷,国外医学泌尿系统分册,1984年,1卷,8页

共引文献5

同被引文献32

  • 1徐颖,徐晓辉.甲亢患者骨密度及骨代谢生化指标的临床观察[J].标记免疫分析与临床,2004,11(2):76-78. 被引量:4
  • 2费朝霞,张作仕,张爱玲,曲宁,王元善.甲状腺功能亢进症患者骨代谢特征与结局[J].中国临床康复,2005,9(23):175-177. 被引量:5
  • 3陆汉魁,余永利,罗全勇,陈立波,朱瑞森.^(131)I治疗分化型甲状腺癌合并远处转移的疗效及影响因素[J].上海第二医科大学学报,2005,25(12):1263-1266. 被引量:29
  • 4王立军,傅海平.甲状腺功能亢进患者血清中β-CTx的变化[J].江西医学检验,2007,25(2):173-173. 被引量:1
  • 5Posen S, Kleerekoper M, Ingham JP, et al.Parathyroid hor- mone assay in clinical desicion- making [ J] Br Med J, 1976,1(6000):16- 19.
  • 6Gamem P, Delmas PD.New developments in biochemical markers for osteoporosis[ J]. Calcif Tissue Int, 1996,59(Suppl 1)S2-9.
  • 7Seibel MJ. Clinical application of biochemical markers of bone turnover[ J]. Arq Bras Endocrinol Metabol, 2006,50 (4) : 603 - 620.
  • 8Miyakawa M, Tsushima T, Demura H.Carboxy - terminal propeptide of type 1 procollagen(P1CP)and carboxy- termi- nal telopeptide of type 1 eollagen(1CTP)as sensitive markers of bone metabolism in thyroid disease[ J]. Endoer J, 1996,43 (6) :701 - 708.
  • 9Dhanwal DK. Thyroid disorders and bone mineral metabolism [J] .Indian J Endocrinol Metab,2001,15(Suppl 2) : S107 - 112.
  • 10Delmas PD. Markers of bone formation and re:8orption[A] .In.Favus MJ,et al(eds).Primer on the metabolic bone disease and disordes of mineral metabolism[ M]. 2nd ed. New York: Raven Press, 1993.108 - 112.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部